Skip to main content
Collaboration Platform > Engineered Pseudomonas aeruginosa

Engineered Pseudomonas aeruginosa

Using synthetic biology, these engineered bacteria can perform many activities to include releasing medically important chemicals and killing cancer cells. Drs. Su, Guo, Samy, and Krishnamoorthy are developing these biotechnologies. The United States of America’s National Science Foundation (NSF) and Open Therapeutics funded a bacterial lytic biotechnology that, in vitro, demonstrates destroying cholesteatoma tumors as an adjunct, or replacement, to skull-based surgery.

 

Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.

Please read our Open Therapeutics’ company whitepaper.